Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2021-01-13 Board/Management Inform…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Board/Management Information Classification · 95% confidence The document is an intimation of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2020. It references regulatory compliance under SEBI regulations and mentions the closure of the trading window for insiders. The document is short (3960 characters) and serves as a notification of an upcoming board meeting rather than containing actual financial results or detailed management discussion. It does not contain financial statements or substantive financial data. Therefore, it is not an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a full Management Report (MDA) or Earnings Release (ER). The document is best classified as a Board/Management Information (MANG) filing, as it announces a board meeting and related procedural information.
2021-01-13 English
Loss of Share Certificates
Regulatory Filings Classification · 90% confidence The document is a brief tabular listing of shareholder information, including folio number, share certificate details, and number of shares. It is addressed to stock exchanges (NSE and BSE) and contains no financial data, management discussion, or report content. The document length is very short (553 characters), and it does not contain any report or announcement text. It appears to be a notification related to shareholding details, but not a major shareholding notification crossing thresholds or a director's dealing. Given the lack of any other specific context, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2021-01-04 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the loss of share certificates and the issuance of duplicate share certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a notification to the stock exchange and shareholders about a procedural matter related to share certificates, not a financial report, management change, or voting result. It does not contain financial data, earnings, or governance details. This type of document is a regulatory announcement related to compliance and disclosure obligations under SEBI regulations, fitting best under Regulatory Filings (RNS). The document length is 4497 characters, and it is a formal notification rather than a report or announcement of a report publication.
2021-01-04 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (325 characters) and consists only of an address to stock exchange listing departments with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. Given the brevity and lack of content, this is likely a regulatory filing or a brief notice without detailed information. According to the rules, such short documents without substantive content are classified as Regulatory Filings (RNS).
2020-12-29 English
This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) ....
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window for designated persons and their immediate relatives in compliance with insider trading regulations. It references the Securities Exchange Board of India (SEBI) regulations and specifies the period of closure related to the announcement of unaudited financial results for a quarter ending December 31, 2020. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results disclosure. It is a regulatory announcement informing stakeholders about trading restrictions, not a financial report or earnings release itself. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (3609 characters), and it is an informational notice rather than a report or detailed filing.
2020-12-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication from Bliss GVS Pharma Ltd. regarding the loss of share certificates and the issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder records. The content is focused on informing the stock exchanges and stakeholders about the administrative action related to share certificates, not about financial results, management changes, or other report types. This type of document is a regulatory announcement related to compliance and shareholder record-keeping, fitting best under Regulatory Filings (RNS). The document length is about 6109 characters, which is sufficient for a detailed regulatory filing but does not contain financial statements or management discussion. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-12-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.